Announcements Trials

Browse Landscape

Sponsor

Conditions

Carcinoma, Renal Cell 13 Prostatic Neoplasms 4 Kidney Neoplasms 4 Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Urethral Neoplasms 2 Osteosarcoma 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Melanoma 2 Lung Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Medullary 2 Carcinoma 2 Adrenocortical Carcinoma 2 von Hippel-Lindau Disease 1 Wilms Tumor 1 Urogenital Neoplasms 1 Ureteral Neoplasms 1 Urachal adenocarcinoma 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sjogren's Syndrome 1 Scleroderma, Systemic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Hormone Refractory Prostate Cancer × cabozantinib × 30 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡